Mike Blue
CEO of HistoSonics, the company behind histotripsy, a non-invasive ultrasound surgical platform; discusses FDA clearance, clinical applications, and company fundraising and milestones.
Top 3 podcasts with Mike Blue
Ranked by the Snipd community
23 snips
Mar 11, 2026 • 2h 46min
Oracle Rips, Ellison's Tech-First Vision, Fertilizer Crisis | Apoorv Agrawal, Owen Jennings, Amjad Masad, Shardul Shah, Mike Blue, Brian Taylor, Ivan Soto-Wright
Mike Blue, CEO of HistoSonics, explains noninvasive ultrasound surgery and FDA milestones. Amjad Masad, founder of Replit, unveils Agent 4, canvas features, and a $400M raise. Owen Jennings from Block breaks down Cash App’s functionalization and AI-driven org changes. Apoorv Agrawal of Altimeter discusses winner-take-most dynamics in consumer AI and durability metrics.
8 snips
Nov 13, 2025 • 34min
Using Sound Waves to Destroy Tumors
Mike Blue, CEO of HistoSonics, shares his fascinating journey from a garage-built ultrasound prototype to an FDA-approved cancer treatment device. He discusses how converging sound waves create bubble clouds that destroy tumors non-invasively. After a setback with a failed clinical trial, he rebranded the technology and attracted funding. Blue also reveals insights from the pivotal HOPE for Liver trial, showcasing impressive results and patient outcomes, while addressing challenges in scaling their innovative treatment for various cancers.
Feb 17, 2026 • 52min
Histotripsy: Changing How We Treat Cancer
Mike Blue, CEO of HistoSonics, leads development of histotripsy, a noninvasive focused-ultrasound method to destroy tumors. He explains how the tech works, the FDA-cleared liver treatment, and plans for kidney, pancreas, and other targets. They discuss patient comfort, quality-of-life benefits, immune effects, and where this approach might fit into cancer care.
